Navigation Links
Chantix: Disenchanting Smokers from Nicotine

The drug licensing body in America has approved the new anti-smoking drug called Chantix, which acts by imitating the effect of nicotine on the body//. Research on the effects of this drug on its users showed that almost half of the users were able to completely quit smoking, which has prompted the European regulators to consider its use in United Kingdom.

The drug, which will be marketed in the UK under the name Champix, effectively blocks the withdrawal symptoms. Manufactured by Pfizer, the global pharmaceutical company, the anti-smoking pill will help many give up on the habit.

Research has indicated that the pill may have some side effects- nausea, but this can be offset when the doses are well spaced out. Statistics have shown that about 12 million adults in the UK smoke and about 114,000 deaths in the UK occur just due to smoking, this pill might just be what the doctor ordered.


'"/>




Page: 1

Related medicine news :

1. Smokers children likely to develop caries
2. Smokers more prone to depression
3. Female Smokers More Prone To Lung Cancer
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women Smokers More Prone To Lung Cancer
6. Creating A Greater Awareness Among Smokers
7. Smokers may differ in their cravings for smoking
8. Trained Counselors Counseling Pregnant Smokers To Quit May Not Work
9. Smokers Avoid Dental Care More Than Others
10. Smokers Face The Risk Of Becoming Blind In Later Life
11. New Vaccination For Smokers To Quit Smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... Clean Earth, Inc., a ... hazardous and non-hazardous materials announced today the acquisition of privately owned AERC ... four additional processing facilities and a vast array of additional technologies, services, and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... the military at the same time by providing Prehospital Trauma Life Support (PHTLS) ... is the world’s premier prehospital trauma education developed in cooperation with the American ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Infection,” which will spark a conversation on the current obstacles facing infection prevention ... of completely preventable deaths caused by these infections. , The print component ...
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Digital Scientists, ... excited to announce the opening of a Greenville, South Carolina location. The ... digital progress in Greenville. , “We’ve been working with South Carolina clients for years ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Global Ampoules Market report provides ... applications and industry chain structure. The Ampoules market analysis ... competitive landscape analysis, and major regions, development status. ... ... providing 10 company profiles and 183 tables and figures ...
(Date:3/24/2017)... 2017  Eli Lilly and Company (NYSE: ... $850 million in its U.S. operations in 2017. ... enterprise, including research laboratories, manufacturing sites, and general ... by demand for Lilly products, as well as ... targeting cancer, pain, diabetes and other unmet medical ...
(Date:3/24/2017)... and GENEVA , March ... on World Tuberculosis Day revitalizes efforts to develop sutezolid ... On World Tuberculosis Day, TB Alliance and the ... the clinical development of sutezolid, an antibiotic drug candidate ... pertains to the development of sutezolid in combination with ...
Breaking Medicine Technology: